Copyright Reports & Markets. All rights reserved.

Global Pradefovir Mesylate Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Pradefovir Mesylate Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 10 mg
    • 1.3.3 45 mg
  • 1.4 Market Analysis by Combination Therapy
    • 1.4.1 Overview: Global Pradefovir Mesylate Tablets Consumption Value by Combination Therapy: 2021 Versus 2025 Versus 2032
    • 1.4.2 Combined With Pegylated Interferon Preparations
    • 1.4.3 Combined With Other Nucleoside Antiviral Drugs
  • 1.5 Market Analysis by Sales Channels
    • 1.5.1 Overview: Global Pradefovir Mesylate Tablets Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
    • 1.5.2 Hospital
    • 1.5.3 Retail
    • 1.5.4 Online
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Pradefovir Mesylate Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Treatment Of Chronic Hepatitis B
    • 1.6.3 Management Of Hepatitis B Patients With Renal Impairment
    • 1.6.4 Long-Term Antiviral Therapy For Chronic Viral Hepatitis
    • 1.6.5 Others
  • 1.7 Global Pradefovir Mesylate Tablets Market Size & Forecast
    • 1.7.1 Global Pradefovir Mesylate Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Pradefovir Mesylate Tablets Sales Quantity (2021-2032)
    • 1.7.3 Global Pradefovir Mesylate Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Xi'an Gelan Xintong Pharmaceutical
    • 2.1.1 Xi'an Gelan Xintong Pharmaceutical Details
    • 2.1.2 Xi'an Gelan Xintong Pharmaceutical Major Business
    • 2.1.3 Xi'an Gelan Xintong Pharmaceutical Pradefovir Mesylate Tablets Product and Services
    • 2.1.4 Xi'an Gelan Xintong Pharmaceutical Pradefovir Mesylate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Xi'an Gelan Xintong Pharmaceutical Recent Developments/Updates
  • 2.2 Xi'an Xintong Pharmaceutical Research
    • 2.2.1 Xi'an Xintong Pharmaceutical Research Details
    • 2.2.2 Xi'an Xintong Pharmaceutical Research Major Business
    • 2.2.3 Xi'an Xintong Pharmaceutical Research Pradefovir Mesylate Tablets Product and Services
    • 2.2.4 Xi'an Xintong Pharmaceutical Research Pradefovir Mesylate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Xi'an Xintong Pharmaceutical Research Recent Developments/Updates

3 Competitive Environment: Pradefovir Mesylate Tablets by Manufacturer

  • 3.1 Global Pradefovir Mesylate Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Pradefovir Mesylate Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Pradefovir Mesylate Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Pradefovir Mesylate Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Pradefovir Mesylate Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Pradefovir Mesylate Tablets Manufacturer Market Share in 2025
  • 3.5 Pradefovir Mesylate Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Pradefovir Mesylate Tablets Market: Region Footprint
    • 3.5.2 Pradefovir Mesylate Tablets Market: Company Product Type Footprint
    • 3.5.3 Pradefovir Mesylate Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Pradefovir Mesylate Tablets Market Size by Region
    • 4.1.1 Global Pradefovir Mesylate Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Pradefovir Mesylate Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Pradefovir Mesylate Tablets Average Price by Region (2021-2032)
  • 4.2 North America Pradefovir Mesylate Tablets Consumption Value (2021-2032)
  • 4.3 Europe Pradefovir Mesylate Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Pradefovir Mesylate Tablets Consumption Value (2021-2032)
  • 4.5 South America Pradefovir Mesylate Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Pradefovir Mesylate Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Pradefovir Mesylate Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Pradefovir Mesylate Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Pradefovir Mesylate Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Pradefovir Mesylate Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Pradefovir Mesylate Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Pradefovir Mesylate Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Pradefovir Mesylate Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Pradefovir Mesylate Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Pradefovir Mesylate Tablets Market Size by Country
    • 7.3.1 North America Pradefovir Mesylate Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Pradefovir Mesylate Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Pradefovir Mesylate Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Pradefovir Mesylate Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Pradefovir Mesylate Tablets Market Size by Country
    • 8.3.1 Europe Pradefovir Mesylate Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Pradefovir Mesylate Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Pradefovir Mesylate Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Pradefovir Mesylate Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Pradefovir Mesylate Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Pradefovir Mesylate Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Pradefovir Mesylate Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Pradefovir Mesylate Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Pradefovir Mesylate Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Pradefovir Mesylate Tablets Market Size by Country
    • 10.3.1 South America Pradefovir Mesylate Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Pradefovir Mesylate Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Pradefovir Mesylate Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Pradefovir Mesylate Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Pradefovir Mesylate Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Pradefovir Mesylate Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Pradefovir Mesylate Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Pradefovir Mesylate Tablets Market Drivers
  • 12.2 Pradefovir Mesylate Tablets Market Restraints
  • 12.3 Pradefovir Mesylate Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Pradefovir Mesylate Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Pradefovir Mesylate Tablets
  • 13.3 Pradefovir Mesylate Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Pradefovir Mesylate Tablets Typical Distributors
  • 14.3 Pradefovir Mesylate Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Pradefovir Mesylate Tablets market size was valued at US$ 25.72 million in 2025 and is forecast to a readjusted size of US$ 104 million by 2032 with a CAGR of 6.5% during review period.
    Pradefovir Mesylate Tablets are a novel liver-targeted nucleoside reverse transcriptase inhibitor indicated for the treatment of chronic hepatitis B. It exerts potent and sustained antiviral activity by inhibiting hepatitis B virus DNA replication following liver-specific metabolic activation. Designed with liver-targeted prodrug technology, this agent significantly increases drug concentration in the liver while reducing systemic exposure, thereby improving renal and skeletal safety issues associated with long-term use of traditional nucleoside analogs. It provides a safer first-line therapeutic option for patients with renal insufficiency or renal injury risk, featuring strong targeting, favorable safety profile, and good clinical compliance.in2025, global Pradefovir Mesylate Tablets production reached approximately 2.1 million bottles.
    Pradefovir Mesylate Tablets is a domestically innovated liver-targeted antiviral drug for chronic hepatitis B. With its core advantages of liver targeting and high safety profile in terms of renal and bone toxicity, it has established differentiated competitiveness in the long-term treatment of chronic hepatitis B. The drug has been included in the national medical insurance catalogue, which significantly lowers the financial barrier for patients and drives rapid growth in its clinical penetration. In the market, it is precisely positioned for patients at risk of renal injury caused by traditional nucleoside analogues and elderly populations. Supported by medical insurance policies, clinical guideline recommendations and academic evidence, it is gradually gaining share in first-line treatment. The overall market is in a transitional stage from introduction to growth phase. Its future growth momentum will mainly come from deeper insurance coverage, increased physician awareness, expanded indications and overseas market potential, while it also faces multiple challenges such as competition from existing first-line drugs, pricing pressure from generics and continuous innovation in new drug research and development.
    This report is a detailed and comprehensive analysis for global Pradefovir Mesylate Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Pradefovir Mesylate Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Pradefovir Mesylate Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Pradefovir Mesylate Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Pradefovir Mesylate Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Pradefovir Mesylate Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Pradefovir Mesylate Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Xi'an Gelan Xintong Pharmaceutical, Xi'an Xintong Pharmaceutical Research, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Pradefovir Mesylate Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    10 mg
    45 mg
    Market segment by Combination Therapy
    Combined With Pegylated Interferon Preparations
    Combined With Other Nucleoside Antiviral Drugs
    Market segment by Sales Channels
    Hospital
    Retail
    Online
    Market segment by Application
    Treatment Of Chronic Hepatitis B
    Management Of Hepatitis B Patients With Renal Impairment
    Long-Term Antiviral Therapy For Chronic Viral Hepatitis
    Others
    Major players covered
    Xi'an Gelan Xintong Pharmaceutical
    Xi'an Xintong Pharmaceutical Research
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Pradefovir Mesylate Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Pradefovir Mesylate Tablets, with price, sales quantity, revenue, and global market share of Pradefovir Mesylate Tablets from 2021 to 2026.
    Chapter 3, the Pradefovir Mesylate Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Pradefovir Mesylate Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pradefovir Mesylate Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Pradefovir Mesylate Tablets.
    Chapter 14 and 15, to describe Pradefovir Mesylate Tablets sales channel, distributors, customers, research findings and conclusion.

    Buy now